ArticleCureus2026
Three Years of Idiopathic Chylous Ascites: Splenic Marginal Zone Lymphoma Behind the Mask.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chylous ascites is rare in adults and is most commonly caused by lymphatic obstruction due to non-Hodgkin B-cell lymphoma. Splenic marginal zone lymphoma (SMZL) is an uncommon etiology. We report the case of an 89-year-old man with a three-year history of refractory chylous ascites initially considered of unknown origin. Clinical examination revealed significant ascites and splenomegaly. PET imaging demonstrated hypermetabolic lymphadenopathy, and bone marrow biopsy revealed infiltration by a CD5-/CD10- B-cell lymphoma consistent with SMZL. Analysis of ascitic fluid showed a predominance of T lymphocytes without a detectable B-cell clone. This case illustrates that SMZL, although rare, should be included in the differential diagnosis of persistent chylous ascites. A comprehensive diagnostic approach combining imaging, bone marrow biopsy, and flow cytometry is essential to establish a timely diagnosis and guide appropriate management, especially in elderly patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.